化合物RA-9 T8464
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 919091-63-7 | ¥983.00 | 询底价 |
10 mg | 919091-63-7 | ¥553.00 | 询底价 |
5 mg | 919091-63-7 | ¥347.00 | 询底价 |
1 mL | 919091-63-7 | ¥379.00 | 询底价 |
50 mg | 919091-63-7 | ¥1,530.00 | 询底价 |
100 mg | 919091-63-7 | ¥2,430.00 | 询底价 |
1 mg | 919091-63-7 | ¥129.00 | 询底价 |
Product Introduction
Bioactivity
英文名: RA-9
描述: RA-9 是一种高选择性蛋白酶体相关的 DUBs 抑制剂,具有良好的毒性和抗癌活性。它阻断泛素依赖性蛋白降解而不影响 20S 蛋白酶体蛋白水解活性。它诱导卵巢癌细胞内质网应激反应,选择性诱导卵巢癌细胞株和供体原代培养细胞凋亡。
动物实验: Mice were inoculated i.p. with 100,000 ES-2 cells (in 100 μl DMEM) stably expressing GFP.?When tumor was detectable (approx.?6 days post inoculation), mice were randomly assigned into two groups receiving RA-9 or 0.9% saline.?Treatment with RA-9 was given i.p. on a one-day on, two-days off schedule.?The control group received the vehicle alone at the same schedule.?Working concentrations of RA-9 (10 mg/ml) were reached by dissolution in Cremophor EL and polyethylene glycol 400 (Sigma).?Prior to each injection RA-9 was further diluted in 0.9% saline (working concentration 1mg/ml).?To monitor for tumor growth, RA-9 treated and control mice were imaged with an IVIS SpectrumCT Pre-clinical in vivo imaging system (PerkinElmer) every other day.?Animals were sacrificed when abdomens became distended to twice normal size.
体外活性: The characterization of RA-9 as a small-molecule inhibitor of proteasome-associated DUBs.?Treatment with RA-9 selectively induces onset of apoptosis in ovarian cancer cell lines and primary cultures derived from donors.?Loss of cell viability following RA-9 exposure is associated with an unfolded protein response as mechanism to compensate for unsustainable levels of proteotoxic stress.
体内活性: In vivo treatment with RA-9 retards tumor growth, increases overall survival, and was well tolerated by the host.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 4 mg/mL (10.95 mM)
关键字: Unfolded | cancer | RA 9 | DUBs | Inhibitor | Apoptosis | Response | Deubiquitinase | cells | inhibit | Protein | RA9 | ovarian | survival | RA-9
相关产品: ISRIB (trans-isomer) | Eragidomide | KRIBB11 | Psoralen | Valepotriate | VTP50469 | Amuvatinib | Diethyl phthalate | Thapsigargin | SZL P1-41
相关库: Anti-Aging Compound Library | Cell Cycle Compound Library | Bioactive Compounds Library Max | Anti-Ovarian Cancer Compound Library | Inhibitor Library | Anti-Cancer Active Compound Library | Highly Selective Inhibitor Library | DNA Damage & Repair Compound Library | Apoptosis Compound Library | Bioactive Compound Library
化合物RA-9 T8464信息由TargetMol中国为您提供,如您想了解更多关于化合物RA-9 T8464报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途